- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04793854
Sickle Cell Disease, Neurocognitive Disorders, Social Participation (SOCIODREP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
France
-
Pointe-à-Pitre, France, Guadeloupe, 97139
- CHU de la Guadeloupe
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Sickle cell anemia
- Age between 6 and 16 years inccuded, attending the centre of reference for sickle cell disease in Guadeloupe
- Informed consent
- Medical insurance
Exclusion Criteria:
- Other sickle cell syndrome other than SS or Sb-thal
- Less than 6 years old or older than 16
- Attending other sickle cell departments
- No medical insurance
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Case
Children with sickle cell anemia attending the centre of reference for sickle cell disease in Guadeloupe.
|
Life habits include daily activities and social in 6 groups. Environmental factors include social (9 different subgroups) and physical factors (7 different subgroups). Personal factors are person related parameters (gender, age, sociocultural ethnic, skills, deficiencies factors,…).
Other Names:
|
|
Control
Control children without chronical disease
|
Life habits include daily activities and social in 6 groups. Environmental factors include social (9 different subgroups) and physical factors (7 different subgroups). Personal factors are person related parameters (gender, age, sociocultural ethnic, skills, deficiencies factors,…).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MHAVIE-Children
Time Frame: Inclusion
|
Assessment of Life Habits-LIFE-H
|
Inclusion
|
|
MQE
Time Frame: Inclusion
|
Measure of Environmental Quality (MQE)
|
Inclusion
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PAP_RNI_2018/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.